To further investigate SRARP‐associated pathways, gene sets that are co‐expressed with SRARP at a CC> 0.6 were identified in breast and prostate cancers using the average linkage hierarchical clustering as explained in methods (Table S6). Here, SRARP is linked to prostate cancer.